Logo image of SAN.PA

SANOFI (SAN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock

83.23 EUR
-0.37 (-0.44%)
Last: 12/9/2025, 5:36:15 PM
Fundamental Rating

6

Taking everything into account, SAN scores 6 out of 10 in our fundamental rating. SAN was compared to 54 industry peers in the Pharmaceuticals industry. While SAN has a great profitability rating, there are some minor concerns on its financial health. SAN has a decent growth rate and is not valued too expensively. Finally SAN also has an excellent dividend rating. With these ratings, SAN could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SAN had positive earnings in the past year.
SAN had a positive operating cash flow in the past year.
Each year in the past 5 years SAN has been profitable.
Each year in the past 5 years SAN had a positive operating cash flow.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of SAN (11.05%) is better than 77.78% of its industry peers.
The Return On Equity of SAN (19.73%) is better than 64.81% of its industry peers.
SAN has a Return On Invested Capital of 13.84%. This is in the better half of the industry: SAN outperforms 68.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 13.89%.
The last Return On Invested Capital (13.84%) for SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 20.35%, SAN is doing good in the industry, outperforming 79.63% of the companies in the same industry.
In the last couple of years the Profit Margin of SAN has grown nicely.
SAN has a Operating Margin of 23.59%. This is comparable to the rest of the industry: SAN outperforms 59.26% of its industry peers.
SAN's Operating Margin has improved in the last couple of years.
SAN has a Gross Margin (71.70%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SAN is creating value.
The number of shares outstanding for SAN remains at a similar level compared to 1 year ago.
The number of shares outstanding for SAN remains at a similar level compared to 5 years ago.
The debt/assets ratio for SAN has been reduced compared to a year ago.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of SAN is 2.21, which is a good value as it means it would take SAN, 2.21 years of fcf income to pay off all of its debts.
SAN has a better Debt to FCF ratio (2.21) than 81.48% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, SAN is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.81
WACC7.63%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SAN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, SAN is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
A Quick Ratio of 0.94 indicates that SAN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, SAN is in line with its industry, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

The Earnings Per Share is expected to grow by 7.11% on average over the next years.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.95, the valuation of SAN can be described as very reasonable.
Based on the Price/Earnings ratio, SAN is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.28. SAN is valued rather cheaply when compared to this.
SAN is valuated reasonably with a Price/Forward Earnings ratio of 9.69.
83.33% of the companies in the same industry are more expensive than SAN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SAN to the average of the S&P500 Index (23.52), we can say SAN is valued rather cheaply.
Industry RankSector Rank
PE 10.95
Fwd PE 9.69
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SAN is on the same level as its industry peers.
SAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.07
EV/EBITDA 10.71
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SAN may justify a higher PE ratio.
PEG (NY)3.63
PEG (5Y)2.15
EPS Next 2Y5.77%
EPS Next 3Y5.98%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.64%, SAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.90, SAN pays a better dividend. On top of this SAN pays more dividend than 87.04% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.64%

5.2 History

The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

34.82% of the earnings are spent on dividend by SAN. This is a low number and sustainable payout ratio.
The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

SANOFI

EPA:SAN (12/9/2025, 5:36:15 PM)

83.23

-0.37 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap202.17B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target107.62 (29.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.64%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)1.13%
PT rev (3m)-1.94%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 10.95
Fwd PE 9.69
P/S 2.98
P/FCF 20.07
P/OCF 17.76
P/B 2.89
P/tB 21.75
EV/EBITDA 10.71
EPS(TTM)7.6
EY9.13%
EPS(NY)8.59
Fwd EY10.32%
FCF(TTM)4.15
FCFY4.98%
OCF(TTM)4.69
OCFY5.63%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.63
PEG (5Y)2.15
Graham Number70.2
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.46%
EBIT Next 3Y13.42%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 6 / 10 to SAN.PA.


What is the valuation status for SAN stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


What is the profitability of SAN stock?

SANOFI (SAN.PA) has a profitability rating of 7 / 10.


What is the expected EPS growth for SANOFI (SAN.PA) stock?

The Earnings per Share (EPS) of SANOFI (SAN.PA) is expected to grow by 3.02% in the next year.


How sustainable is the dividend of SANOFI (SAN.PA) stock?

The dividend rating of SANOFI (SAN.PA) is 8 / 10 and the dividend payout ratio is 34.82%.